LONDON (Alliance News) - Verona Pharma PLC Monday posted a widened pretax loss for 2013 as it continued to develop its two pipeline drugs towards commercialisation. Veron posted a pretax loss of GBP2.8 million, widened from a pretax loss of GBP2.6 million in 2012, as administration expense Read More

UK MIDDAY BRIEFING: Boohoo.com Latest On IPO Catwalk

7th Mar 2014 12:51

LONDON (Alliance News) - Online fashion retailer <strong>Boohoo.com</strong>, the latest UK retailer to firm up its initial public offering, has said it plans to raise GBP300 million in the AIM listing, giving it a higher-then-expected initial market capitalisation of GBP560 million.<br /><br Read More

UK WINNERS & LOSERS: Aviva Leads Blue-Chip Risers Again

7th Mar 2014 10:57

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Friday. ------- FTSE 100 - WINNERS Aviva, up 4.2%. After closing as the blue-chip index's biggest riser on Thursday, Aviva is again the stand out performer Frid Read More

Verona Pharma Looks To Raise Up To GBP14 Million In Share Placing

6th Mar 2014 18:02

LONDON (Alliance News) - Verona Pharma PLC Thursday said it intends to raise up to GBP14 million before expenses in a share placing, subscription, and open offer, which it said it will use to fund further development of its RPL554 drug. The drug development company focuses on medicines to t Read More

FTSE 100 Latest

Value8,809.74

Change53.53